Switching from Aspirin to Clopidogrel for Mild Hematuria in Stroke Patients

Guideline-Based Rationale

The American College of Chest Physicians recommends clopidogrel 75 mg once daily as an equivalent first-line antiplatelet option for long-term secondary stroke prevention in patients with noncardioembolic ischemic stroke or TIA (Grade 1A) 1, 2.
The American College of Chest Physicians suggests clopidogrel or aspirin/extended-release dipyridamole over aspirin monotherapy (Grade 2B) for long-term secondary stroke prevention in patients with noncardioembolic ischemic stroke or TIA 1, 2, 4.
The American Heart Association/American Stroke Association guidelines state that for patients intolerant to aspirin because of allergy or gastrointestinal side effects, clopidogrel is an appropriate choice 3.

The CAPRIE trial demonstrated that clopidogrel 75 mg daily was at least as effective as aspirin 325 mg daily for preventing vascular events in patients with prior stroke, with an annual rate of ischemic stroke, MI, or vascular death of 7.15% with clopidogrel versus 7.71% with aspirin 5.
Clopidogrel has fewer gastrointestinal symptoms and hemorrhages compared to aspirin, making it particularly suitable for patients experiencing aspirin-related bleeding complications 5.
The overall safety of clopidogrel is comparable to aspirin with only minor differences, and gastrointestinal hemorrhages are actually less frequent with clopidogrel 5.

The American Heart Association/American Stroke Association guidelines recommend against using dual antiplatelet therapy (aspirin plus clopidogrel) in chronic secondary stroke prevention (Class III, Level of Evidence A) 3, 6.
Before switching to clopidogrel, ensure the patient does not have atrial fibrillation requiring anticoagulation, as oral anticoagulation is preferred over antiplatelet therapy in this population 1, 2, 7.
Before switching to clopidogrel, ensure the patient does not have cardioembolic stroke etiology, as anticoagulation may be more appropriate 1, 2.

Switch directly to clopidogrel 75 mg once daily without a loading dose in the chronic setting, as recommended by the American College of Chest Physicians 1, 2.
Discontinue aspirin when initiating clopidogrel to avoid unnecessary bleeding risk from dual therapy, as recommended by the American Heart Association/American Stroke Association 3, 6.
Monitor for resolution of hematuria after the switch, which should occur if aspirin was the causative agent, and investigate the hematuria to exclude underlying urological pathology 1, 3.
Avoid proton pump inhibitors if possible, as they can reduce clopidogrel effectiveness, and use H2 blockers if antacid therapy is needed, as suggested by clinical evidence 5.